
Delix Therapeutics
Developer of neuroscience therapeutics designed to address mental health and central nervous system conditions. The company's platform discovers and develops non-hallucinogenic small molecules that in...
Valuation
$0
Share Price
N/A
Total Raised
$108.5M
Last Round
N/A